Dow Up 0.36% Nasdaq Up 0.12%

Aegerion Pharmaceuticals, Inc. (AEGR)

-NasdaqGS
30.11 0.98(3.15%) Aug 21, 4:00PM EDT
Prev Close:31.09
Open:31.17
Bid:29.00 x 100
Ask:34.20 x 100
1y Target Est:66.10
Beta:0.63
Earnings Date:Oct 28 - Nov 3 (Est.)
Day's Range:30.05 - 31.80
52wk Range:26.25 - 101.00
Volume:980,174
Avg Vol (3m):1,040,360
Market Cap:888.03M
P/E (ttm):N/A
EPS (ttm):-2.09
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for AEGR

Comparison

Symbol% ChgMkt Cap
AEGRDown 3.15%888.03M
AZN92.44B
MRK169.76B
PFE182.74B

Key Statistics

Forward P/E (1 yr):14.48
P/S (ttm):8.83
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.86
Quarterly EPS Est (Sep-14) :-0.13
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):-0.03

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Aegerion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapies for patients with debilitating rare diseases in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback